Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of LIFECORE BIOMEDICAL, INC. \DE\ from 28 May 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 28 May 2017 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 30 Sep 2025 was $1,363,000, a 54% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $197,000, a 98% increase from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $10,629,000, a 161% decline from 2022.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $17,448,000, a 4914% increase from 2021.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,363,000 +$1,579,000 +54% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q3 2024 $2,942,000 +$7,507,000 +72% 27 May 2024 25 Aug 2024 10-Q 06 Nov 2025 2026 Q1
Q3 2023 $10,449,000 -$13,028,000 -505% 29 May 2023 27 Aug 2023 10-Q 04 Oct 2024 2025 Q1
Q3 2022 $2,579,000 +$2,427,000 +1597% 30 May 2022 28 Aug 2022 10-Q 09 Aug 2024 2024 Q1
Q3 2021 $152,000 -$77,000 -34% 31 May 2021 29 Aug 2021 10-K 20 Mar 2024 2023 FY
Q3 2020 $229,000 -$681,000 -75% 01 Jun 2020 30 Aug 2020 10-K 20 Mar 2024 2023 FY
Q3 2019 $910,000 +$2,442,000 27 May 2019 25 Aug 2019 10-Q 07 Oct 2020 2021 Q1
Q3 2018 $1,532,000 -$4,314,000 -155% 28 May 2018 26 Aug 2018 10-Q 03 Oct 2019 2020 Q1
Q3 2017 $2,782,000 29 May 2017 27 Aug 2017 10-Q 05 Oct 2018 2019 Q1

LIFECORE BIOMEDICAL, INC. \DE\ Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $197,000 +$10,432,000 +98% 27 May 2024 25 May 2025 10-K 07 Aug 2025 2025 FY
2023 $10,629,000 -$28,077,000 -161% 29 May 2023 26 May 2024 10-K 07 Aug 2025 2025 FY
2022 $17,448,000 +$17,100,000 +4914% 30 May 2022 28 May 2023 10-K 26 Aug 2024 2024 FY
2021 $348,000 -$394,000 -53% 31 May 2021 29 May 2022 10-K 26 Aug 2024 2024 FY
2020 $742,000 +$1,654,000 01 Jun 2020 30 May 2021 10-K 20 Mar 2024 2023 FY
2019 $912,000 +$839,000 +48% 27 May 2019 31 May 2020 10-K 14 Aug 2020 2020 FY
2018 $1,751,000 +$767,000 +30% 28 May 2018 26 May 2019 10-K 14 Aug 2020 2020 FY
2017 $2,518,000 +$1,867,000 +43% 29 May 2017 27 May 2018 10-K 14 Aug 2020 2020 FY
2016 $4,385,000 30 May 2016 28 May 2017 10-K 01 Aug 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.